keyword
https://read.qxmd.com/read/38593584/stroma-areactive-invasion-front-areas-sarifa-a-novel-histopathologic-biomarker-in-colorectal-cancer-patients-and-its-association-with-the-luminal-tumour-proportion
#21
JOURNAL ARTICLE
N G Reitsam, B Grosser, J S Enke, W Mueller, A Westwood, N P West, P Quirke, B Märkl, H I Grabsch
BACKGROUND: Stroma AReactive Invasion Front Areas (SARIFA) is a novel prognostic histopathologic biomarker measured at the invasive front in haematoxylin & eosin (H&E) stained colon and gastric cancer resection specimens. The aim of the current study was to validate the prognostic relevance of SARIFA-status in colorectal cancer (CRC) patients and investigate its association with the luminal proportion of tumour (PoT). METHODS: We established the SARIFA-status in 164 CRC resection specimens...
April 8, 2024: Translational Oncology
https://read.qxmd.com/read/38592721/anti-egfr-rechallenge-in-patients-with-refractory-ctdna-ras-braf-wt-metastatic-colorectal-cancer-a-nonrandomized-controlled-trial
#22
JOURNAL ARTICLE
Davide Ciardiello, Erika Martinelli, Teresa Troiani, Gianluca Mauri, Daniele Rossini, Giulia Martini, Stefania Napolitano, Vincenzo Famiglietti, Sara Del Tufo, Gianluca Masi, Daniele Santini, Antonio Avallone, Filippo Pietrantonio, Sara Lonardi, Massimo Di Maio, Maria Giulia Zampino, Nicola Fazio, Alberto Bardelli, Salvatore Siena, Chiara Cremolini, Andrea Sartore-Bianchi, Fortunato Ciardiello
IMPORTANCE: The available evidence regarding anti-epidermal growth factor receptor (EGFR) inhibitor rechallenge in patients with refractory circulating tumor DNA (ctDNA) RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC) is derived from small retrospective and prospective studies. OBJECTIVE: To evaluate the efficacy of anti-EGFR rechallenge in patients with refractory ctDNA RAS/BRAF wt mCRC. DESIGN, SETTING, AND PARTICIPANTS: This nonrandomized controlled trial used a pooled analysis of individual patient data from patients with RAS/BRAF wt ctDNA mCRC enrolled in 4 Italian trials (CAVE, VELO, CRICKET, and CHRONOS) and treated with anti-EGFR rechallenge between 2015 and 2022 (median [IQR] follow-up, 28...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38591098/switching-from-folfiri-plus-cetuximab-to-folfiri-plus-bevacizumab-based-on-early-tumor-shrinkage-in-ras-wild-type-metastatic-colorectal-cancer-a-phase-ii-trial-hybrid
#23
JOURNAL ARTICLE
Hiroyuki Arai, Takashi Tsuda, Yu Sunakawa, Mototsugu Shimokawa, Kohei Akiyoshi, Shinya Tokunaga, Hirokazu Shoji, Kenji Kunieda, Masahito Kotaka, Toshihiko Matsumoto, Yusuke Nagata, Takuro Mizukami, Fumitaka Mizuki, Kathleen D Danenberg, Narikazu Boku, Takako Eguchi Nakajima
BACKGROUND: Long-term anti-EGFR antibody treatment increases the risk of severe dermatologic toxicities. This single-arm, phase II trial aimed to investigate the strategy of switching from cetuximab to bevacizumab in combination with FOLFIRI based on early tumor shrinkage (ETS) in patients with RAS wild-type metastatic colorectal cancer (mCRC). METHODS: Radiologic assessment was performed to evaluate ETS, defined as ≥20% reduction in the sum of the largest diameters of target lesions 8 weeks after the introduction of FOLFIRI plus cetuximab...
April 2024: Cancer Medicine
https://read.qxmd.com/read/38590019/a-systematic-review-and-meta-analysis-of-oncological-outcomes-with-transanal-total-mesorectal-excision-for-rectal-cancer
#24
REVIEW
Emma Neary, Tarek Ibrahim, Chris P Verschoor, Lisa Zhang, Sunil V Patel, Sami A Chadi, Antonio Caycedo-Marulanda
AIM: Transanal total mesorectal (taTME) excision is a method used to assist in the radical removal of the rectum. By adopting the concept of natural orifice surgery, it offers potential benefits over conventional techniques. Early enthusiasm for this strategy led to its rapid and widespread adoption. The imposing of a local moratorium was precipitated by the discovery in Norway of an uncommon multifocal pattern of locoregional recurrence. The aim of this systematic review and meta-analysis was to determine the incidence of local recurrence after taTME for rectal cancer...
April 8, 2024: Colorectal Disease
https://read.qxmd.com/read/38590005/intracorporeal-anastomosis-could-be-associated-with-a-higher-lymph-node-yield-in-right-colon-cancer-surgery-results-of-the-ica-latam-study-a-retrospective-multicentre-comparative-analysis-in-latin-america
#25
JOURNAL ARTICLE
Juan C Patrón Uriburu, Sergio Araujo, Abedrapo Mario, Jimenez Billy, Ramón Méndez, Gustavo Rossi, Nicolás Rotholtz, Romagnolo Luis, Nicolas Avellaneda, Armando Melani
AIM: The aim of this work was to compare lymph node (LN) yield in patients operated on for right colon cancer (RCC) using a laparoscopic approach between those receiving an intracorporeal (ICA) or extracorporeal anastomosis (ECA). METHOD: This is a retrospective multicentre study involving patients operated on for RCC in nine tertiary referral centres in Latin America during a 2-year period. The main comparative outcome between groups was the number of LNs harvested between groups...
April 8, 2024: Colorectal Disease
https://read.qxmd.com/read/38582795/extraperitoneal-lateral-pelvic-sidewall-excision-a-novel-rectal-sparing-approach-for-lateral-locally-recurrent-rectal-cancer
#26
JOURNAL ARTICLE
Luca Sorrentino, Gaia Colletti, Filiberto Belli, Alessandro Gronchi
Locally recurrent rectal cancer (LRRC) involving the lateral pelvic sidewall requires a complex approach to maximize the likelihood of R0 resection, which is the only predictor of survival. The purpose of this report is to describe a novel technique to resect a localized lateral pelvic sidewall LRRC. A 63-year-old male patient was referred for a 15-mm LRRC near the right internal iliac vessels. Endoscopic ultrasound and magnetic resonance imaging excluded any involvement of the pelvic colon or residual rectum...
April 6, 2024: Updates in Surgery
https://read.qxmd.com/read/38581083/quantified-trends-in-provider-reimbursement-and-utilization-volume-in-colorectal-cancer-screenings-analysis-of-medicare-claims-from-2000-to-2019
#27
JOURNAL ARTICLE
Vishal M Bommineni, Vikas L Bommineni, Rohan Gupta
AIM: Colorectal cancer (CRC) screening rates in the United States remain persistently below guideline targets, partly due to suboptimal patient utilization and provider reimbursement. To guide long-term national utilization estimates and set reasonable screening adherence targets, this study aimed to quantify trends in utilization of and reimbursement for CRC screenings using Medicare claims. METHOD: Inflation-adjusted reimbursements and utilization volume associated with each CRC screening code were abstracted from Medicare claims between 2000 and 2019...
April 5, 2024: Colorectal Disease
https://read.qxmd.com/read/38577466/high-patatin-like-phospholipase-domain-containing-8-expression-as-a-biomarker-for-poor-prognosis-of-colorectal-cancer
#28
JOURNAL ARTICLE
Peng-Yang Zhou, De-Xiang Zhu, Yi-Jiao Chen, Qing-Yang Feng, Yi-Hao Mao, Ao-Bo Zhuang, Jian-Min Xu
BACKGROUND: Patatin like phospholipase domain containing 8 (PNPLA8) has been shown to play a significant role in various cancer entities. Previous studies have focused on its roles as an antioxidant and in lipid peroxidation. However, the role of PNPLA8 in colorectal cancer (CRC) progression is unclear. AIM: To explore the prognostic effects of PNPLA8 expression in CRC. METHODS: A retrospective cohort containing 751 consecutive CRC patients was enrolled...
March 15, 2024: World Journal of Gastrointestinal Oncology
https://read.qxmd.com/read/38576543/robotic-low-anterior-resection-with-complete-splenic-flexure-mobilization-and-defunctioning-left-sided-loop-colostomy-a-case-series
#29
Martin Rutegård, Anders Gerdin, Jannice Forssell, Olle Sjöström, Andreas Söderström, Petrus Vinnars
A defunctioning stoma is used to alleviate the consequences of anastomotic leakage after low anterior resection for rectal cancer. A loop ileostomy is often preferred but may lead to dehydration and kidney injury. Here, we present a case series for an alternative: the left-sided loop colostomy. A convenience sample of four patients underwent robotic low anterior resection for rectal cancer. A complete splenic flexure mobilization and a total mesorectal excision were performed. To defunction the anastomosis, the redundant left colon was brought up to a stoma site in the left iliac fossa and matured as a loop colostomy...
January 2024: Journal of Surgical Case Reports
https://read.qxmd.com/read/38576078/can-robotic-surgery-lead-the-way-in-the-treatment-of-rectal-cancer
#30
JOURNAL ARTICLE
Jeonghee Han
No abstract text is available yet for this article.
April 5, 2024: Annals of Coloproctology
https://read.qxmd.com/read/38576073/perioperative-and-oncological-outcomes-following-robotic-en-bloc-multivisceral-resection-for-colorectal-cancer
#31
JOURNAL ARTICLE
Sandra R DiBrito, Naveen Manisundaram, Youngwan Kim, Oliver Peacock, Chung-Yuan Hu, Brian Bednarski, Y Nancy You, Abhineet Uppal, Matthew Tillman, Tsuyoshi Konishi, Harmeet Kaur, Sarah Palmquist, Emma Holliday, Arvind Dasari, George J Chang
AIM: As multidisciplinary treatment strategies for colorectal cancer have improved, aggressive surgical resection has become commonplace. Multivisceral and extended resections offer curative-intent resection with significant survival benefit. However, limited data exist regarding the feasibility and oncological efficacy of performing extended resection via a minimally invasive approach. The aim of this study was to determine the perioperative and long-term outcomes following robotic extended resection for colorectal cancer...
April 4, 2024: Colorectal Disease
https://read.qxmd.com/read/38569485/outcome-of-colorectal-robotic-surgery-in-newly-established-robotic-surgery-center-a-case-series
#32
JOURNAL ARTICLE
Ahmed A Alkhamis, Diaa M Soliman, Khaled A Alsadder, Hashem M Busalha, Ahmad S Alrashed, Bader H Alshaban, Salman K Alsafran, Sulaiman M Almazeedi
INTRODUCTION: The robotic platform compared to laparoscopy has proven to have similar postoperative outcomes, however its adoption in the Middle East has been slow and there is limited data regarding outcomes with its use in small newly established robotic colorectal programs. Our aim was to report our experience and outcomes of robotic colorectal surgery performed by fellowship-trained robotic colorectal surgeons and compare them to larger, more experienced centers. METHODS: This is retrospective review of data collected between November 2021 and March 2023 from a tertiary health care referral center...
April 3, 2024: Medical Principles and Practice: International Journal of the Kuwait University, Health Science Centre
https://read.qxmd.com/read/38567167/synchronous-papillary-thyroid-cancer-and-colorectal-cancer-in-a-young-patient-with-a-chek2-mutation
#33
Sydney Brooke Hoskins, Leslie Torgerson
INTRODUCTION: Mutations of CHEK2 are usually inherited and have been implicated in breast cancers, colorectal cancers, thyroid cancers, kidney cancers, and prostate cancers. The CHEK2 gene codes for checkpoint kinase 2 protein which is an effector in the ATM-CHEK2-p53 pathway and responds to DNA double-strand breaks. CASE PRESENTATION: We describe a unique case of a 29-year-old Canadian female who presented with synchronous papillary thyroid carcinoma and rectal adenocarcinoma who was subsequently found to have a sporadic CHEK2 (checkpoint kinase 2) mutation...
2024: Case Reports in Oncology
https://read.qxmd.com/read/38566765/epidemiological-insights-into-colorectal-cancer-in-northwestern-algeria
#34
JOURNAL ARTICLE
Salah Eddine El Herrag, Soraya Moulessehoul, Douniazad El Mehadji, Djamila Yekrou, Méghit Boumediène Khaled
OBJECTIVES: The incidence of colorectal cancer (CRC) has exhibited regional variability in North Africa and the Middle East, with a steady increase in Algeria. Despite this trend, limited data exist on the epidemiology of CRC in northwestern Algeria. Our study aimed to investigate the epidemiological characteristics of CRC in this region. METHODS: We conducted a retrospective study examining 255 confirmed CRC cases through medical records from patients at the Sidi Bel Abbes anti-cancer centre...
2024: Ecancermedicalscience
https://read.qxmd.com/read/38566456/contemporary-results-from-the-pelvex-collaborative-improvements-in-surgical-outcomes-for-locally-advanced-and-recurrent-rectal-cancer
#35
JOURNAL ARTICLE
(no author information available yet)
AIM: The PelvEx Collaborative collates global data on outcomes following exenterative surgery for locally advanced and locally recurrent rectal cancer (LARC and LRRC, respectively). The aim of this study is to report contemporary data from within the collaborative and benchmark it against previous PelvEx publications. METHOD: Anonymized data from 45 units that performed pelvic exenteration for LARC or LRRC between 2017 and 2021 were reviewed. The primary endpoints were surgical outcomes, including resection margin status, radicality of surgery, rates of reconstruction and associated morbidity and/or mortality...
April 2, 2024: Colorectal Disease
https://read.qxmd.com/read/38566354/robotic-surgery-after-total-neoadjuvant-therapy-for-rectal-cancer-pitfalls-of-beyond-total-mesorectal-excision-for-patients-with-sidewall-invasion
#36
JOURNAL ARTICLE
Kenta Iguchi, Masakatsu Numata, Yosuke Atsumi, Tsutomu Sato, Yasushi Rino, Aya Saito
AIM: Total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC) is rapidly spreading. The robotic surgical techniques to approach lateral invasion, such as that of the pelvic plexus, have not yet been established. In this technical note, we present a video illustrating a surgical technique for lateral invasion using our novel technique and discuss its pitfalls. METHOD: We present the case of a 65-year-old man with LARC. Robotic surgery was performed after TNT using the da Vinci Xi Surgical System (Intuitive Surgical Inc...
April 2, 2024: Colorectal Disease
https://read.qxmd.com/read/38565871/early-screening-of-colorectal-cancer-using-feature-engineering-with-artificial-intelligence-enhanced-analysis-of-nanoscale-chromatin-modifications
#37
JOURNAL ARTICLE
Andrew Chang, Sravya Prabhala, Ali Daneshkhah, Jianan Lin, Hariharan Subramanian, Hemant Kumar Roy, Vadim Backman
Colonoscopy is accurate but inefficient for colorectal cancer (CRC) prevention due to the low (~ 7 to 8%) prevalence of target lesions, advanced adenomas. We leveraged rectal mucosa to identify patients who harbor CRC field carcinogenesis by evaluating chromatin 3D architecture. Supranucleosomal disordered chromatin chains (~ 5 to 20 nm, ~1 kbp) fold into chromatin packing domains (~ 100 to 200 nm, ~ 100 to 1000 kbp). In turn, the fractal-like conformation of DNA within chromatin domains and the folding of the genome into packing domains has been shown to influence multiple facets of gene transcription, including the transcriptional plasticity of cancer cells...
April 2, 2024: Scientific Reports
https://read.qxmd.com/read/38564083/outcomes-in-robotic-assisted-compared-to-laparoscopic-assisted-colorectal-surgery-in-a-newly-established-colorectal-tertiary-center-a-retrospective-comparative-cohort-study
#38
JOURNAL ARTICLE
Ahmed Alkhamis, Diaa Soliman, Omar Alkandari, Ahmad Alrashed, Mohammad Alansari, Khaled Alsadder, Zeinab Chamkha, Dante Souza, Bader AlShaban, Salman Alsafran, Sulaiman Almazeedi
The robotic platform matches or surpasses laparoscopic surgery in postoperative results. However, limited date and slow adoption are noticed in the middle east. We aimed to report outcomes of robotic and laparoscopic colorectal surgery performed by fellowship-trained robotic colorectal surgeons and compare it to larger more experienced centers. Retrospective review of prospectively collected data between 2021 and 2023 of 107 patients who had robotic-assisted or laparoscopic-assisted colorectal surgery was included in the study...
April 2, 2024: Journal of Robotic Surgery
https://read.qxmd.com/read/38561492/convolutional-neural-network-deep-learning-model-accurately-detects-rectal-cancer-in-endoanal-ultrasounds
#39
JOURNAL ARTICLE
D Carter, D Bykhovsky, A Hasky, I Mamistvalov, Y Zimmer, E Ram, O Hoffer
BACKGROUND: Imaging is vital for assessing rectal cancer, with endoanal ultrasound (EAUS) being highly accurate in large tertiary medical centers. However, EAUS accuracy drops outside such settings, possibly due to varied examiner experience and fewer examinations. This underscores the need for an AI-based system to enhance accuracy in non-specialized centers. This study aimed to develop and validate deep learning (DL) models to differentiate rectal cancer in standard EAUS images. METHODS: A transfer learning approach with fine-tuned DL architectures was employed, utilizing a dataset of 294 images...
April 1, 2024: Techniques in Coloproctology
https://read.qxmd.com/read/38559545/perirectal-mucinous-adenocarcinoma-after-subtotal-colectomy-for-crohn-s-disease-a-case-report
#40
Matthew S Wishnoff, Ashley Shustak, Steven Sharp
Colorectal carcinoma (CRC) represents the third most common cancer and the second highest cause of cancer-related death in the United States. CRC is particularly prevalent in patients with underlying inflammatory bowel disease. Adenocarcinoma represents more than 90% of new CRC diagnoses. The mucinous subtype of colorectal adenocarcinoma is found in approximately 10-20% of all colorectal cancer patients and is most frequently located in the proximal colon. We report a case of mucinous adenocarcinoma arising from the rectal stump of a patient who had previously undergone subtotal-colectomy with end ileostomy for Crohn's disease...
March 2024: Curēus
keyword
keyword
57987
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.